Govt moves to rein in online advertisements of high-risk medicines
The draft proposal, now before the Drugs Controller General of India (DCGI), focuses on strengthening enforcement by amending the Drugs and Cosmetics Rules, 1945 and closing a major regulatory loophole. Currently, drug licences do not explicitly ban advertising—the draft proposes a ban on advertising high-risk Schedule G, H, H1, and X drugs as a mandatory…